Industry Trends
What Does the Democratic Sweep Mean for US Cannabis?
Last week’s US midterm elections have transformed the political map of the country, handing both the House and the Senate over to the Democrats.
Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
1,838stories
10 Novlast updated
More in Ben Stevens
- M&A Activity
Organigram Blows Curaleaf’s Aurora Bid Out of the Water With $561m Offer
Curaleaf Holding’s months-long hostile takeover bid for Aurora Cannabis has been blown out of the water by Organigram Global, which has now tabled a significantly higher bid.
- Medical Cannabis
DEA Issues First Federal Registrations to 900 Dispensaries, But Dual-Licence States Remain Uncertain
More than 900 US medical cannabis dispensaries have become the first operators in the country to hold federal registration, marking the first tangible change for operators since April’s partial rescheduling order.
- Medical Cannabis
Germany’s Cannabis Flower Patients Face Years of Litigation After Constitutional Shortcut Blocked
German patients challenging the recent controversial changes to medical cannabis reimbursement via statutory health insurance (GKV) are facing lengthy battles across the country’s courts.
- Hemp Industry
Whole Hemp Plant Could Soon Be Recognised as Agricultural Crop in the EU, but States Will Keep Power to Criminalise
The Council of the European Union has adopted proposals that would see the whole hemp plant, including inflorescences and leaves, recognised as an ordinary agricultural product.
- Hemp Industry
German Cannabis Pioneer SynBiotic SE Files For Insolvency
SynBiotic SE, once one of the largest and most promising cannabis companies in Germany, has announced plans to file for insolvency and had its shares suspended on the Xetra and Frankfurt stock exchanges.
- Cultivation
Does Your Cannabis Prescription Match the Name on the Label?
Medical cannabis’s cultivar names have, over the past two years, become an increasingly controversial part of the European prescription framework.
- Cultivation
Six-Month Bedrolite Supply Secured for UK Patients But Long-Term Access Remains Uncertain
UK medical cannabis patients have been told that they’ll have access to a six-month stockpile of Bedrolite, following weeks of uncertainty in the wake of Bedrocan’s collapse.
- US & Canada
Fight Over US Cannabis Contract Enforcement Rights Could Come Back to Court
A Michigan cultivator is fighting to overturn a landmark court decision which has thrown the enforceability of cannabis industry contracts across the US into question.
